First female CEO of GSK to be paid 25% less than her male predecessor
Clouds Are Gathering (Again) For GSK | Seeking Alpha
GlaxoSmithKline Deal for Tesaro: It's the Wrong Medicine - Bloomberg
GSK Pharmaceuticals India: net assets 2022 | Statista
Why GSK should turn down Unilever's billions | MoneyWeek
GSK: cash flow 2022 | Statista
GSK delivers FY 2021 reported sales of £34 billion, stable at AER, +5% CER; Total EPS 87.6p -24% AER, -13% CER and Adjusted EPS of 113.2p -2% AER, +9% CER | GSK
GSK (LSE:GSK) - Stock Price, News & Analysis - Simply Wall St
GlaxoSmithKline Pharma Q2 net up 3% to Rs 193 cr, revenue down to Rs 906 cr
GSK to buy US biotech group Affinivax in $3bn deal | Financial Times
Are GSK's legal troubles a threat to the firm's survival? | MoneyWeek
GlaxoSmithKline rewards CEO Walmsley with a 17% pay bump, to £8.2 million | Fierce Pharma
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
Academic Researchers Escape Scrutiny in Glaxo Fraud Settlement
GSK Stock Price and Chart — LSE:GSK — TradingView
GSK spins off Haleon in biggest European listing in decade | HealthCare Middle East & Africa Magazine
GSK plc - Wikipedia
GlaxoSmithKline (GSK): What Could Give Us An Upside Here | Seeking Alpha
Financial Ratio Analysis of AstraZeneca and GlaxoSmithKline
Glaxosmithkline Pharma Q1 Results: Net profit rises 8% to Rs 116 crore - The Economic Times
GSK's drugs arm to get $11 bln booster from consumer spin-off | Reuters
GlaxoSmithKline : Top 20 Pharmaceutical Companies in 2021 | Contract Pharma
GSK plc - Wikipedia
Is GSK A Good Choice For Dividend Investors? | Seeking Alpha
GSK to buy Bellus for $2 billion to gain cough medicine - Times of India
GSK shown up by AstraZeneca yet again | Financial Times
GSK to boost spending power of pharma business post break-up
Will GlaxoSmithKline deal be worth it for Unilever?
GSK Cuts Return to Shareholders From Novartis Asset Swap - WSJ
